Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Firmenich & Novozymes partner for great-tasting yogurt with unprecedented sugar reduction performance 2020-10-07 20:00
Nagase R&D Center Increases Productivity of Rare Amino Acid "Ergothioneine" 1000-fold: Highest Production Efficiency Reported Using "Smart Cell" Technology 2020-10-07 14:00
First Commercial Drug Manufactured via Ajinomoto Bio-Pharma Services' AJIPHASE Technology Receives FDA Approval 2020-10-06 22:20
Thailand's Eastern Economic Corridor to Become Post-COVID Global Food Innovation Hub 2020-10-06 12:18
CARsgen Therapeutics Granted Orphan Drug Designation by the US FDA for CT041 CLDN18.2 CAR-T Cells for the Treatment of Gastric and Gastroesophageal Junction Cancers 2020-10-05 18:00
Happiness Biotech Announced Receipt of FDA Registration For Its Hand Sanitizer 2020-10-01 22:00
OriCiro Launches World's First Cell-Free Amplification Technology for Large Circular DNA 2020-09-30 21:47
Firmenich Opens New Era in Ingredient Creation with Launch of Biotech and Naturals Pilot Plant in Geneva 2020-09-30 21:36
TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand 2020-09-30 15:51
ILIAS Biologics Closes $20.6 Million Series B Financing 2020-09-28 19:00
World's first clinical trial of non-viral PD1 specific targeted CAR T therapy achieves great breakthroughs 2020-09-28 19:00
Carmine Therapeutics named as one of FierceBiotech's "Fierce 15" Biotech Companies of 2020 2020-09-28 18:00
TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Injection) ORIENT-32 Study Met Its Primary Endpoints of Progression-Free Survival and Overall Survival in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma (HCC) 2020-09-28 10:15
InventisBio Announces $147 Million Series D Financing Led by Hillhouse Affiliate GL Ventures 2020-09-28 05:00
Radius Health & Menarini Group Provide Elacestrant Update 2020-09-25 18:15
Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by U.S. FDA 2020-09-25 10:37
Cell Signaling Technology Named a Top Charitable Company in Massachusetts by the Boston Business Journal 2020-09-24 20:00
KYAN Therapeutics Exclusively Licenses Small Molecule HDAC Inhibitors for AI-Powered Cancer Drug Development 2020-09-24 17:12
Macrogen, K-Quarantine System "Smart Mobile Lab" Exported to Indonesia 2020-09-24 09:00
SEMI-NBMC Invites White Paper Proposals for Funding of Human Monitoring Innovations 2020-09-24 07:11
1 275 276 277 278 279 451